Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery

NCT00880542 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped The study lost funding.

Conditions

Sarcoma

Interventions

DRUG: sorafenib
DRUG: Ifosfamide

Sponsor

Jonsson Comprehensive Cancer Center